Us Bancorp \De\ Galmed Pharmaceuticals Ltd. Transaction History

Us Bancorp \De\

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$3.61 - $6.75 $6,786 - $12,690	-1,880 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$5.68 - $8.68 $2,840 - $4,340	-500 Reduced 21.01%	1,880 $14,000
Q1 2019 May 08, 2019	BUY	$7.27 - $9.07 $617 - $770	85 Added 3.7%	2,380 $19,000
Q4 2018 Feb 13, 2019	BUY	$6.59 - $14.47 $12,652 - $27,782	1,920 Added 512.0%	2,295 $15,000
Q2 2018 Aug 08, 2018	BUY	$5.04 - $17.96 $1,890 - $6,735	375 New	375 $4,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $62.5M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.